“2015梅斯医学移动医疗创新大赛”报名启动

2015-05-20 MedSci MedSci原创

移动医疗充满机会,但也亟待资源整合。由梅斯医学举办的“2015梅斯医学移动医疗创新大赛”报名通道今天正式启动,本届大赛以“医路相伴,共赢未来”为主题,寻找改善患者就医体验的移动医疗方案,挖掘互联网时代给移动医疗带来的创新策略,助力医疗及临床医学研究,提高临床诊疗效率。 本届大赛将从所有参赛项目中筛选出10-15个项目参加决赛,优秀团队可获得资金奖励,一等奖(1名)奖励20万;二等奖(3名)奖

移动医疗充满机会,但也亟待资源整合。由梅斯医学举办的“2015梅斯医学移动医疗创新大赛”报名通道今天正式启动,本届大赛以“医路相伴,共赢未来”为主题,寻找改善患者就医体验的移动医疗方案,挖掘互联网时代给移动医疗带来的创新策略,助力医疗及临床医学研究,提高临床诊疗效率。

本届大赛将从所有参赛项目中筛选出10-15个项目参加决赛,优秀团队可获得资金奖励,一等奖(1名)奖励20万;二等奖(3名)奖金5万;三等奖(5名)奖金1万,当然,优胜团队也可获得“梅斯医学”后续开发者合作支持以及平台推广。

决赛将于2015年6月28日在京举行,届时大赛将邀请移动医疗圈内权威人士,共同商讨移动医疗现状和发展方向。同时,对进入决赛的项目进行评分以及颁奖。

【参赛要求】

以医生为项目的主导者,项目有临床专家作为核心团队支持,或在医院工作并对移动医疗感兴趣的个人或者团队都可参加

【项目要求】

1,独立设计一个具有创新性和实用性的移动医疗应用系统或软件架构;
2,考虑整体的解决方案,而不仅限于技术平台的展示(暂无技术平台也可)

以上两点都不具备也没关系,只要你有想法,就带着你的创想来这里,实现你的移动医疗梦。

【参赛流程】

大赛报名:截止时间6月19日

项目筛选:截止时间6月27日

决赛及颁奖:2015年6月28日

【报名方式】

请点击大会官网http://medsci.cn/z/ydly0515/

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1741140, encodeId=c1381e41140c5, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Thu Mar 24 21:04:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276767, encodeId=23a412e6767e0, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285207, encodeId=4848128520e8b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530415, encodeId=e3581530415bf, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24324, encodeId=5e562432452, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Thu May 21 08:02:00 CST 2015, time=2015-05-21, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1741140, encodeId=c1381e41140c5, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Thu Mar 24 21:04:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276767, encodeId=23a412e6767e0, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285207, encodeId=4848128520e8b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530415, encodeId=e3581530415bf, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24324, encodeId=5e562432452, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Thu May 21 08:02:00 CST 2015, time=2015-05-21, status=1, ipAttribution=)]
    2015-05-22 一闲
  3. [GetPortalCommentsPageByObjectIdResponse(id=1741140, encodeId=c1381e41140c5, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Thu Mar 24 21:04:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276767, encodeId=23a412e6767e0, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285207, encodeId=4848128520e8b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530415, encodeId=e3581530415bf, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24324, encodeId=5e562432452, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Thu May 21 08:02:00 CST 2015, time=2015-05-21, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1741140, encodeId=c1381e41140c5, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Thu Mar 24 21:04:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276767, encodeId=23a412e6767e0, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285207, encodeId=4848128520e8b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530415, encodeId=e3581530415bf, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24324, encodeId=5e562432452, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Thu May 21 08:02:00 CST 2015, time=2015-05-21, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1741140, encodeId=c1381e41140c5, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Thu Mar 24 21:04:00 CST 2016, time=2016-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276767, encodeId=23a412e6767e0, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285207, encodeId=4848128520e8b, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530415, encodeId=e3581530415bf, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Fri May 22 09:04:00 CST 2015, time=2015-05-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=24324, encodeId=5e562432452, content=关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJUNfdk68bHutYruGyxbKDzPWH3agcmId19Yf94FiapyicN0LTg0jykhqIhjPQVdR08FGR399rBpZIg/132, createdBy=feae1624323, createdName=Dr.LV, createdTime=Thu May 21 08:02:00 CST 2015, time=2015-05-21, status=1, ipAttribution=)]
    2015-05-21 Dr.LV

    关注

    0

相关资讯

移动医疗峰会 2015:Dr.2谈移动医疗竞争格局现状,大赞MedSci

由生物谷主办的“2015(第二届)移动医疗健康峰会”在北京辰茂鸿翔酒店隆重开幕。知名财经作家、《估值就是讲故事》《移动医疗那点事》《反精益创业》等书的作者,来自医库软件科技有限公司的Dr.2获邀参加了此次峰会,并做了题为“移动医疗竞争格局现状”的精彩演讲。Dr.2重点分析了阿里健康四大平台布局医疗;腾讯的问诊+移动支付战略;百度硬件+数据+就诊战略;小米以硬件入口为核心,占领客厅的策略,以及春雨医

2015GMIC移动医疗受追捧 百度医生成热门应用

4月28日,全球移动互联网大会(简称GMIC)在北京开幕,全球知名的IT企业和行业精英齐聚,共同探讨移动互联网面临的机遇和挑战。与往年各种新潮硬件、手机、游戏各领风骚的场景不同,今年GMIC上最火爆的话题却是“移动医疗”。这是GMIC首次设立移动医疗分会场,邀请了众多传统医疗行业的专家学者参加,现场听众的热情完全出乎主办方的预料,会场里过道上都站满了听众,以至于要用保安堵在门口阻止更多听众入场。百

移动医疗模式与典型公司介绍

无论从哪个方向深入探寻商业模式,由于医生资源仍旧牢牢束缚在公立医院的高墙之内,因此移动医疗公司真正核心的问题是如何撬动这块资源。现在的消费型移动医疗设备,大多集中于某些简单数据的监测与记录上,缺乏对数据的深度挖掘,互动性较差。 2003年科学家完成人类基因组图谱,自此医疗科技取得了巨大的进步。新型的医疗健康模式和工具,将改变人们传统的监测、看病、保健的方式,并逐步形成一条新的产业链。从预防到看

刘谦:移动医疗如何征服市场?

刘谦从事处方药营销近20年,在诺华、辉瑞、阿斯利康和GSK等一线外企担任过事业部总监、企业战略负责人等职务,并在亚太区和全球总部工作3年。擅长处方药品牌策略诊断与制定,医院销售团队能力发展,数字化营销和合规化营销。经常在国内医药论坛担任演讲嘉宾,并在医药经理人、医药经济报和医药战略等媒体发表过十余篇文章。微信号:rogerjx720 上周末在北京参加了两场移动医疗创业大赛,本来很担心

苹果HealthKit成功整合电子病历,将来有望改变移动医疗版图

这家科技巨头连接了健康追踪软件Healthkit和位于洛杉矶的赛达斯-西奈医疗中心(Cedars-Sinai Medical Center )的病历档案,这也是迄今为止苹果在健康领域发起的最大规模的整合。 西奈医疗中心首席信息官Darren Dworkin在采访中透露,本周医院升级电子病历系统后,将为超过8万名患者开放HealthKit通道。“我们并不完全清楚病人将会如何使用这项功能,但我们

重要通知:2015“梅斯医学”移动医疗创新大赛即将启动

背景介绍 医疗设备正逐渐从“可携式”发展为“可穿戴式”或“口袋式”,这意味着医疗设备由只能间断、偶尔对健康监测,转变为长期、连续监测,这也给医疗健康数据的诠释带来新的挑战: 移动医疗作为一个颠覆者介入到非常传统的医疗行业时,面临巨大的壁垒,包括监管层面的和实际应用层面的问题。如何保障安全,有效地诊断? 医生离开医院的重型设备,能明确诊断、给出合理化建议吗?轻问诊模式会随着